Delivery Order SPE2DR25D2214-SPE2DR26FV6P2
- Not listed
- The Defense Logistics Agency awarded a $6,497.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 22, 2025, with a completion date of January 14, 2026. This non-set-aside competitive award represents a single delivery order for the lupus treatment medication to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector, with an ultimate completion date of October 16, 2025. This non-competitive, firm fixed-price delivery order represents a single purchase of this biologic medication used primarily in the treatment of systemic lupus erythematosus. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Benlysta 200 mg/mL auto-injector, a pharmaceutical product used in the treatment of systemic lupus erythematosus. This firm fixed-price delivery order, valued at $6,497.32, is set to be completed by January 6, 2026, and represents a non-competitive, competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The work will be performed at the...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Benlysta 200 mg/ml auto-injector, a specialty pharmaceutical product used in the treatment of systemic lupus erythematosus. This non-set-aside, competitively awarded contract carries a ceiling value of $6,165.34 and is classified as a firm fixed price delivery order with an ultimate completion date of September 26, 2025. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Benlysta 200 mg/ml auto-injectors, a biologic medication used to treat systemic lupus erythematosus. This firm fixed-price delivery order carries a ceiling value of $3,248.66 and is scheduled for completion by December 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Benlysta 200 mg/mL auto-injector units, a biologic medication used to treat systemic lupus erythematosus. This competitively awarded, non-set-aside delivery order carries a ceiling value of $12,994.64 with a firm fixed price structure and an ultimate completion date of January 9, 2026. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,987.78 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on May 13, 2025, with completion expected by June 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis, representing a...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus, reflecting the breadth of specialty pharmaceuticals...
- SPE2DR25D2214Indefinite Delivery Contract
- SPE2DR25D2214-SPE2DR26FV6P2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on December 2, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor for a specialty medication used in the treatment of systemic lupus erythematosus. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. As a prime vendor vehicle for global pharmaceutical support, the IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's role as a critical federal medical procurement vendor allows it to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 12/1/25 |